KEVIN ERICKSON to Kidney Failure, Chronic
This is a "connection" page, showing publications KEVIN ERICKSON has written about Kidney Failure, Chronic.
Connection Strength
11.389
-
In-center hemodialysis unit patient experience with telehealth. Hemodial Int. 2023 04; 27(2):193-196.
Score: 0.501
-
Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 01 17; 329(3):205-206.
Score: 0.499
-
A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
Score: 0.485
-
Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 06; 33(6):1063-1072.
Score: 0.471
-
Market Consolidation and Innovation in US Dialysis. Adv Chronic Kidney Dis. 2022 01; 29(1):65-75.
Score: 0.464
-
The beneficial effect of providing kidney transplantation information on transplantation status differs between for-profit and nonprofit dialysis centers. Transpl Int. 2021 12; 34(12):2644-2668.
Score: 0.463
-
How Did Medicare Payment Reform Affect Highly Concentrated Dialysis Markets? JAMA Health Forum. 2021 11 02; 2(11):e213378.
Score: 0.459
-
Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
Score: 0.456
-
Payer Mix Among Patients Receiving Dialysis. JAMA. 2020 09 01; 324(9):900-901.
Score: 0.423
-
Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
Score: 0.407
-
Physician reimbursement for outpatient dialysis care: Past, present, and future. Semin Dial. 2020 01; 33(1):68-74.
Score: 0.405
-
Consolidation in dialysis Markets-Causes, consequences, and the role of policy. Semin Dial. 2020 01; 33(1):90-99.
Score: 0.405
-
The dialysis care-policy issue: Guest Editors' introductory remarks. Semin Dial. 2020 01; 33(1):4.
Score: 0.405
-
Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127.
Score: 0.392
-
Integrated Care in ESKD: A Perspective of Nephrologists. Clin J Am Soc Nephrol. 2019 03 07; 14(3):451-453.
Score: 0.379
-
Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Intern Med. 2018 10 01; 178(10):1358-1367.
Score: 0.371
-
Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
Score: 0.366
-
The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
Score: 0.363
-
Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
Score: 0.351
-
Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
Score: 0.315
-
Measuring comorbidity in patients receiving dialysis: can we do better? Am J Kidney Dis. 2015 Nov; 66(5):731-4.
Score: 0.297
-
Overlooked care transitions: an opportunity to reduce acute care use in ESRD. Clin J Am Soc Nephrol. 2015 Mar 06; 10(3):347-9.
Score: 0.288
-
Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
Score: 0.286
-
Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7.
Score: 0.284
-
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1250-8.
Score: 0.253
-
Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
Score: 0.251
-
Geographic Dialysis Facility Density and Early Dialysis Initiation. JAMA Netw Open. 2024 Jan 02; 7(1):e2350009.
Score: 0.133
-
Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline. J Gen Intern Med. 2023 Nov; 38(14):3198-3208.
Score: 0.129
-
Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
Score: 0.112
-
Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery. J Am Soc Nephrol. 2020 03; 31(3):602-614.
Score: 0.102
-
Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208.
Score: 0.094
-
Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
Score: 0.094
-
Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
Score: 0.093
-
Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
Score: 0.093
-
Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
Score: 0.088
-
A Case for More Frequent, Not Just Earlier, Nephrology Care of Patients Approaching ESRD? Am J Kidney Dis. 2017 08; 70(2):155-157.
Score: 0.085
-
Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
Score: 0.068
-
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2013 Sep 17; 159(6):382-9.
Score: 0.065
-
Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD. Clin J Am Soc Nephrol. 2013 Jan; 8(1):75-81.
Score: 0.061
-
Hemodialysis treatment center early mortality rates for incident hemodialysis patients are associated with the quality of care prior to starting but not following onset of dialysis. Am J Nephrol. 2011; 33(5):390-7.
Score: 0.055
-
The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5.
Score: 0.054
-
Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):536-545.
Score: 0.020